These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12798337)
21. Investigating chelating sulfonamides and their use in metalloproteinase inhibitors. Tanakit A; Rouffet M; Martin DP; Cohen SM Dalton Trans; 2012 Jun; 41(21):6507-15. PubMed ID: 22411188 [TBL] [Abstract][Full Text] [Related]
22. Sulfonamide-based acyclic and conformationally constrained MMP inhibitors: from computer-assisted design to nanomolar compounds. Hanessian S; Moitessier N Curr Top Med Chem; 2004; 4(12):1269-87. PubMed ID: 15320726 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and application of isocyanates radiolabeled with carbon-11. Wilson AA; Garcia A; Houle S; Sadovski O; Vasdev N Chemistry; 2011 Jan; 17(1):259-64. PubMed ID: 21207622 [TBL] [Abstract][Full Text] [Related]
24. Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer. Wang M; Lacy G; Gao M; Miller KD; Sledge GW; Zheng QH Bioorg Med Chem Lett; 2007 Jan; 17(2):332-6. PubMed ID: 17095221 [TBL] [Abstract][Full Text] [Related]
25. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation. Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974 [TBL] [Abstract][Full Text] [Related]
26. Effects of biphenyl sulfonylamino methyl bisphosphonic acids on Porphyromonas gingivalis and cytokine secretion by oral epithelial cells. Zhao L; Marquis A; La VD; Agamennone M; Loiodice F; Tortorella P; Grenier D Med Chem; 2013 Sep; 9(6):855-60. PubMed ID: 23061603 [TBL] [Abstract][Full Text] [Related]
27. Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases. Pikul S; Ohler NE; Ciszewski G; Laufersweiler MC; Almstead NG; De B; Natchus MG; Hsieh LC; Janusz MJ; Peng SX; Branch TM; King SL; Taiwo YO; Mieling GE J Med Chem; 2001 Aug; 44(16):2499-502. PubMed ID: 11472202 [No Abstract] [Full Text] [Related]
28. Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation. Hugenberg V; Riemann B; Hermann S; Schober O; Schäfers M; Szardenings K; Lebedev A; Gangadharmath U; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S J Med Chem; 2013 Sep; 56(17):6858-70. PubMed ID: 23899323 [TBL] [Abstract][Full Text] [Related]
29. Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents. Oltenfreiter R; Staelens L; Kersemans V; Cornelissen B; Frankenne F; Foidart JM; Van de Wiele C; Slegers G Appl Radiat Isot; 2006 Jun; 64(6):677-85. PubMed ID: 16546398 [TBL] [Abstract][Full Text] [Related]
34. The synthesis and biological activity of a novel series of diazepine MMP inhibitors. Levin JI; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Skotnicki JS; Albright JD Bioorg Med Chem Lett; 1998 Oct; 8(19):2657-62. PubMed ID: 9873598 [TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of conformationally-constrained MMP inhibitors. Natchus MG; Cheng M; Wahl CT; Pikul S; Almstead NG; Bradley RS; Taiwo YO; Mieling GE; Dunaway CM; Snider CE; McIver JM; Barnett BL; McPhail SJ; Anastasio MB; De B Bioorg Med Chem Lett; 1998 Aug; 8(16):2077-80. PubMed ID: 9873489 [TBL] [Abstract][Full Text] [Related]
36. alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. Biasone A; Tortorella P; Campestre C; Agamennone M; Preziuso S; Chiappini M; Nuti E; Carelli P; Rossello A; Mazza F; Gallina C Bioorg Med Chem; 2007 Jan; 15(2):791-9. PubMed ID: 17088065 [TBL] [Abstract][Full Text] [Related]
37. Solid-phase combinatorial synthesis of peptide-biphenyl hybrids as calpain inhibitors. Montero A; Albericio F; Royo M; Herradón B Org Lett; 2004 Oct; 6(22):4089-92. PubMed ID: 15496106 [TBL] [Abstract][Full Text] [Related]
38. A novel series of highly selective inhibitors of MMP-3. Whitlock GA; Dack KN; Dickinson RP; Lewis ML Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors. Hopper DW; Vera MD; How D; Sabatini J; Xiang JS; Ipek M; Thomason J; Hu Y; Feyfant E; Wang Q; Georgiadis KE; Reifenberg E; Sheldon RT; Keohan CC; Majumdar MK; Morris EA; Skotnicki J; Sum PE Bioorg Med Chem Lett; 2009 May; 19(9):2487-91. PubMed ID: 19329309 [TBL] [Abstract][Full Text] [Related]
40. Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET. Wagner S; Breyholz HJ; Law MP; Faust A; Höltke C; Schröer S; Haufe G; Levkau B; Schober O; Schäfers M; Kopka K J Med Chem; 2007 Nov; 50(23):5752-64. PubMed ID: 17956082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]